Date Filed | Type | Description |
08/23/2023 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 2,132 shares
@ $107.388, valued at
$229k
|
|
05/11/2023 |
4/A
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC |
02/08/2023 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 1,041 shares
@ $105.8035, valued at
$110.1k
Sold 1,522 shares
@ $102.2427, valued at
$155.6k
Sold 12,801 shares
@ $102.4191, valued at
$1.3M
Sold 911 shares
@ $104.0779, valued at
$94.8k
|
|
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2022 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 10,000 shares
@ $111.0446, valued at
$1.1M
Exercised 10,000 options to buy
@ $43.24, valued at
$432.4k
|
|
09/09/2022 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Gifted 100 shares
@ $0 Gifted 100 shares
@ $0 |
|
03/22/2022 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 300 shares
@ $95, valued at
$28.5k
Sold 8,455 shares
@ $95.051, valued at
$803.7k
|
|
02/09/2022 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 605 shares
@ $80.5444, valued at
$48.7k
Sold 1,522 shares
@ $80.7802, valued at
$122.9k
Sold 1,041 shares
@ $80.7382, valued at
$84k
Sold 911 shares
@ $79.511, valued at
$72.4k
|
|
02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/29/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/16/2020 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 2,257 shares
@ $90.7198, valued at
$204.8k
|
|
08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/25/2020 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 5,000 shares
@ $130, valued at
$650k
Exercised 5,000 options to buy
@ $32.99, valued at
$165k
|
|
05/20/2020 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 5,000 shares
@ $120, valued at
$600k
Exercised 5,000 options to buy
@ $32.99, valued at
$165k
|
|
04/28/2020 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 1,934 shares
@ $99.4912, valued at
$192.4k
|
|
02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/07/2020 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 1,145 shares
@ $102.8825, valued at
$117.8k
Sold 605 shares
@ $103.1513, valued at
$62.4k
Sold 1,198 shares
@ $101.4655, valued at
$121.6k
Granted 49,844 options
@ $102.9, valued at
$5.1M
Granted 7,897 restricted stock units
@ $0 |
|
11/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/05/2019 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 6,736 shares
@ $100, valued at
$673.6k
Exercised 6,736 options to buy
@ $32.99, valued at
$222.2k
|
|
08/27/2019 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 1,664 shares
@ $100.0931, valued at
$166.6k
Sold 1,600 shares
@ $100, valued at
$160k
Exercised 1,664 options to buy
@ $32.99, valued at
$54.9k
Exercised 1,600 options to buy
@ $32.99, valued at
$52.8k
|
|
07/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/07/2018 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 1,979 shares
@ $88.4738, valued at
$175.1k
Exercised 1,979 options to buy
@ $18.15, valued at
$35.9k
|
|
02/07/2018 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 1,979 shares
@ $83.1138, valued at
$164.5k
Sold 758 shares
@ $83.1295, valued at
$63k
Paid exercise price by delivering 787 shares
@ $82.48, valued at
$64.9k
Exercised 1,979 options to buy
@ $18.15, valued at
$35.9k
Granted 26,050 options
@ $81.49, valued at
$2.1M
Granted 4,600 restricted stock units
@ $0 Granted 12,250 restricted stock units
@ $0 |
|
01/04/2018 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 1,979 shares
@ $79.36, valued at
$157.1k
Exercised 1,979 options to buy
@ $18.15, valued at
$35.9k
|
|
01/02/2018 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 15,237 shares
@ $75, valued at
$1.1M
Exercised 15,237 options to buy
@ $18.15, valued at
$276.6k
|
|
12/11/2017 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 2,955 shares
@ $75, valued at
$221.6k
Exercised 2,955 options to buy
@ $18.15, valued at
$53.6k
|
|
|